SCHEMBL6784467

SCHEMBL6784467

COc1ccc(N(C)c2ccccc2-c2ccccc2)cc1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ ACACA Q13085 1/20 0.43
▸ HTT P42858 2/20 0.42
▸ USP2 O75604 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ TUBB4A P04350 1/20 0.40
▸ TUBB P07437 1/20 0.40
▸ TUBA3C P0DPH7 1/20 0.40
▸ CES1 P23141 1/20 0.40
▸ TUBA1B P68363 1/20 0.40
▸ TUBA4A P68366 1/20 0.40
▸ TUBB4B P68371 1/20 0.40
▸ TUBB3 Q13509 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6778392 0.83 CES1 (0.49) ACACACES1NPC1EGFRPDGFRB
SCHEMBL6778756 0.82 MTNR1A (0.49) ALDH1A1KMT2AKDM4EHSD17B10HTT
SCHEMBL4859689 0.79 CSF1R (0.49) ALDH1A1MEN1KMT2AHPGDL3MBTL1
SCHEMBL3370037 0.78 TACR1 (0.41) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL28281092 0.78 HTT (0.50) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL13826147 0.77 TAAR1 (0.39) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL6723970 0.77 TAAR1 (0.39) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL6723824 0.77 TAAR1 (0.39) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL6723985 0.77 TAAR1 (0.39) ALDH1A1MEN1KMT2AKDM4EHSD17B10
SCHEMBL13826295 0.76 PSMB5 (0.41) MEN1KMT2AKDM4EHTTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT ALDH1A1 646/4885MEN1 4612/4885KMT2A 1440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback